178 related articles for article (PubMed ID: 37780485)
1. COTE1 Facilitates Intrahepatic Cholangiocarcinoma Progression via Beclin1-Dependent Autophagy Inhibition.
Zhang H; Chen S; Xu S; Li X
Biomed Res Int; 2023; 2023():5491682. PubMed ID: 37780485
[TBL] [Abstract][Full Text] [Related]
2. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
[TBL] [Abstract][Full Text] [Related]
3. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
Chen J; Gao Z; Li X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Luo X; Gao Q; Ding G; Song K; Zhou J; Fan J; Fu X; Ding Z
Cancer Med; 2023 Jan; 12(1):459-471. PubMed ID: 35676831
[TBL] [Abstract][Full Text] [Related]
4. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.
Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X
Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407
[TBL] [Abstract][Full Text] [Related]
7. Ectopic overexpression of COTE1 promotes cellular invasion of hepatocellular carcinoma.
Zhang H; Huang CJ; Tian Y; Wang YP; Han ZG; Li XC
Asian Pac J Cancer Prev; 2012; 13(11):5799-804. PubMed ID: 23317259
[TBL] [Abstract][Full Text] [Related]
8. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
[TBL] [Abstract][Full Text] [Related]
9. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
10. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
11. MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition.
Gao C; Li J; Zeng F; Wang L; Chen K; Chen D; Hong J; Qu C
Carcinogenesis; 2023 Jun; 44(4):279-290. PubMed ID: 37185675
[TBL] [Abstract][Full Text] [Related]
12. Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
Wu L; Yang J; Ke RS; Liu Y; Guo P; Feng L; Li Z
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101999. PubMed ID: 35870795
[TBL] [Abstract][Full Text] [Related]
13. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
15. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1.
Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
[TBL] [Abstract][Full Text] [Related]
16. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy.
Shu B; Zhou Y; Liang Q; He C; Li F
Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781
[TBL] [Abstract][Full Text] [Related]
17. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
[TBL] [Abstract][Full Text] [Related]
18. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
19. [Silencing SIRT1 reduces 5-fluorouracil resistance of cholangiocarcinoma cells by inhibiting the FOXO1/Rab7 autophagy pathway].
Xin C; Wang X; Li X; Chen Y; Wang X; Ning J; Yang S; Wang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):454-459. PubMed ID: 37087591
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
Zhang C; Bai DS; Huang XY; Shi GM; Ke AW; Yang LX; Yang XR; Zhou J; Fan J
PLoS One; 2013; 8(1):e54619. PubMed ID: 23349941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
